Artemisinin is an anti-malaria medication with no side-effects that has activity against 115 kinds of cancer in vitro.

It comes from Sweet Wormwood (Artemisia annua), a traditionally Chinese plant that, thanks to ArtemiFlow™️, can now be produced at low cost and at large scale in the U.S.

ArtemiFlow™️ companies offer solutions that deliver controlled doses of artemisinin through a range of products for humans and pets designed to be integrated into daily life. 

Currently in clinical trials for prostate and ovarian cancer, ArtemiFlow™️ aims to produce the first over-the-counter cancer medication with efficacy against cancer recurrence.